Ibrutinib Added to Standard Conditioning and As Consolidation Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Results from the US Intergroup Double-Blind Randomized Phase III Study Alliance A051301/BMT-CTN 1201
- Citation:
- Blood vol 41 (Supplement 1) 437
- Meeting Instance:
- ASH 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171; U10CA180820, UG1CA233234 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Charalambos Andreadis Olivia Bobek Susan Geyer Timothy Fenske Brian Hill Patrick Stiff Eric Hsi Mitchell Horwitz Farhad Khiman Rich Little Shira Dinner Jonathan Friedberg Brad Kahl Miguel Perales Steven Devine John Leonard Nancy Bartlett
- Networks:
- CA136, IL017, LAPS-IL036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-NY016, LAPS-OH007, LAPS-WI013, NY018, OH027, PA121
- Study
- Alliance-A051301
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: